MedTech Spectrum

Article Name Clinical & Diagnostic

MD Anderson and TOPPAN Forge Alliance to Advance invivoid™ 3D Organoid Technology for Personalized Cancer Therapy

Partnership aims for CAP/CLIA certification of organoid-based assay to guide patient-specific treatment decisions; $10 million investment to fuel clinical validation across multiple cancer types

30th July, 2025

Matrix Medical Network Partners with Molecular Testing Labs to Elevate Home-Based Diagnostics and Expand Access to Care

Strategic alliance enhances in-home screening with advanced molecular diagnostics, AI-driven insights, and flexible testing options to improve outcomes for patients and underserved communities.

29th July, 2025

Aptitude Medical Secures $9M BARDA Partnership to Advance Rapid Filovirus Diagnostic for Ebola and Marburg Detection

New Metrix Filovirus Panel to deliver 30-minute, lab-quality results from blood samples in remote and point-of-care settings—marking a pivotal step in global outbreak preparedness.

29th July, 2025

Linus Health Expands Access to AI-Powered Cognitive Assessments with Launch of ‘Anywhere’ Platform

Designed for seamless remote use, the ‘Anywhere powered by Linus Health™’ platform brings early detection of cognitive decline to payers, pharma, wellness providers, and consumers—anytime, anywhere.

29th July, 2025

Vietnam Makes History with First Robotic-Guided Paediatric Epilepsy Surgery

Vinmec Central Park pioneers breakthrough treatment using AutoGuide™ system, offering new hope for children with drug-resistant epilepsy and marking a significant leap towards global neurological care standards.

29th July, 2025

Roche Secures CE Mark for Alzheimer’s Blood Test

New minimally invasive diagnostic aids in ruling out Alzheimer’s disease early, expanding access to timely and accurate neurological assessments across Europe.

24th July, 2025

Philips Secures FDA Clearance for Image-Guided Navigation Technology in Prostate Cancer Care

Breakthrough Minimally Invasive Solution Enhances Precision in Targeted Therapy Procedures, Supporting Improved Outcomes in Prostate Cancer Treatment

24th July, 2025

Rebuilding the Drug Repurposing Pipeline with Better Data

How high-quality, integrated datasets are transforming drug repurposing from opportunistic discovery to systematic innovation in therapeutic development.

23rd July, 2025

Onco-Innovations Appoints Dr. Dennis Hall to Scientific & Clinical Advisory Board

Renowned oncology expert joins to support advancement of next-generation cancer diagnostics and therapeutics.

21st July, 2025

NeoCast™ Liquid Embolic Shows Promise as Pain-Free Treatment for Chronic Subdural Hematoma

Next-generation embolic technology enables rapid resorption and improved patient comfort in minimally invasive neurointervention

17th July, 2025

Erbe Launches FiAPC® plus to Elevate Argon Plasma Coagulation Precision

Next-Generation Technology Enhances Control, Safety, and Efficiency in Flexible Endoscopic Procedures

15th July, 2025

VISIE Executes First Pin-Free Knee Bone Cuts Using Spatial Computing

Breakthrough Procedure Marks a Milestone in Orthopedic Surgery with Pin-Free Navigation and Augmented Reality-Driven Precision

10th July, 2025

U.S. FDA Grants Breakthrough Device Designation to Artera’s AI-Powered Prostate Cancer Decision Support Tool

Innovative software platform leverages artificial intelligence to personalize therapy decisions and improve clinical outcomes for prostate cancer patients.

10th July, 2025

Mann Eye Institute Unveils Pioneering Treatment for Dry AMD

New Therapeutic Breakthrough Offers Hope for Patients with Geographic Atrophy, the Advanced Form of Dry Age-Related Macular Degeneration

10th July, 2025

Empatica Launches EmbraceMini: World’s Smallest Actigraphy Wearable for Clinical Trials

Designed for long-term monitoring and patient comfort, EmbraceMini sets a new benchmark in wearable technology for decentralized and real-world evidence studies.

27th June, 2025

MolecuLight Unveils Advanced Multimodal Imaging with Thermal Capabilities at St. Louis Wound & Vascular Symposium

New imaging innovation enhances wound assessment by combining fluorescence and thermal data for improved diagnostic precision and patient care

23rd June, 2025

Hera Biotech Acquires HeraFem to Advance High-Sensitivity Cervical Cancer Diagnostics

Acquisition boosts Hera’s women’s health platform with 91% sensitivity point-of-care test, strengthening early cervical cancer detection capabilities.

18th June, 2025